Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

ERISA Recap: 4 Rulings Worth Paying Attention To From Nov. No Photo Available

Kellie Mejdrich

The Ninth Circuit striking down a class action win for transgender employee health plan participants who said their gender-affirming c... (more story)

CDC Panel Ends Recommendation Of Hepatitis B Shot At Birth No Photo Available

Yeji Jesse Lee

A panel of federal vaccine advisers on Friday voted to lift a long-standing recommendation that all newborns be given vaccinations for hepatitis B.

Lawyers Adapt To Crop Of New FDA Pilots No Photo Available

Yeji Jesse Lee

A slew of new FDA pilot programs is forcing life science attorneys to adjust to a new reality of programs that shed bureaucratic proce... (more story)